Histone deacetylases inhibitors in neurodegenerative diseases, neuroprotection and neuronal differentiation

S Shukla, BL Tekwani - Frontiers in pharmacology, 2020 - frontiersin.org
Histone deacetylases (HADC) are the enzymes that remove acetyl group from lysine residue
of histones and non-histone proteins and regulate the process of transcription by binding to …

[HTML][HTML] Epigenetic regulation of astrocyte function in neuroinflammation and neurodegeneration

M Neal, JR Richardson - Biochimica et Biophysica Acta (BBA)-Molecular …, 2018 - Elsevier
Epigenetic mechanisms control various functions throughout the body, from cell fate
determination in development to immune responses and inflammation. Neuroinflammation …

Crossing epigenetic frontiers: the intersection of novel histone modifications and diseases

W Yao, X Hu, X Wang - Signal Transduction and Targeted Therapy, 2024 - nature.com
Histone post-translational modifications (HPTMs), as one of the core mechanisms of
epigenetic regulation, are garnering increasing attention due to their close association with …

Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson's disease?

IF Harrison, DT Dexter - Pharmacology & therapeutics, 2013 - Elsevier
Parkinson's disease (PD) is the most common movement disorder affecting more than 4
million people worldwide. The primary motor symptoms of the disease are due to …

Genetics and epigenetics of Parkinson′ s disease

F Coppedè - The Scientific World Journal, 2012 - Wiley Online Library
In 1997 a mutation in the a-synuclein (SNCA) gene was associated with familial autosomal
dominant Parkinson's disease (PD). Since then, several loci (PARK1‐15) and genes have …

Targeting epigenetic modifications in Parkinson's disease therapy

D Zhang, J Zhang, Y Wang, G Wang… - Medicinal Research …, 2023 - Wiley Online Library
Parkinson's disease (PD) is a multifactorial disease due to a complex interplay between
genetic and epigenetic factors. Recent efforts shed new light on the epigenetic mechanisms …

[HTML][HTML] Pathological histone acetylation in Parkinson's disease: Neuroprotection and inhibition of microglial activation through SIRT 2 inhibition

IF Harrison, AD Smith, DT Dexter - Neuroscience letters, 2018 - Elsevier
Parkinson's disease (PD) is associated with degeneration of nigrostriatal neurons due to
intracytoplasmic inclusions composed predominantly of a synaptic protein called α …

Environmental impact on the epigenetic mechanisms underlying Parkinson's disease pathogenesis: a narrative review

E Angelopoulou, YN Paudel, SG Papageorgiou… - Brain Sciences, 2022 - mdpi.com
Parkinson's disease (PD) is the second most common neurodegenerative disorder with an
unclear etiology and no disease-modifying treatment to date. PD is considered a …

[HTML][HTML] Role of histone deacetylases and their inhibitors in neurological diseases

LY Zhang, SY Zhang, R Wen, TN Zhang… - Pharmacological …, 2024 - Elsevier
Histone deacetylases (HDACs) are zinc-dependent deacetylases that remove acetyl groups
from lysine residues of histones or form protein complexes with other proteins for …

Beneficial effects of sodium butyrate in 6-OHDA induced neurotoxicity and behavioral abnormalities: modulation of histone deacetylase activity

S Sharma, R Taliyan, S Singh - Behavioural brain research, 2015 - Elsevier
Parkinson's disease (PD) is the second most common neurodegenerative disorder. Recent
studies have investigated the involvement of epigenetic modifications in PD. Histone …